Forte Biosciences (FBRX) Reports In-Line Q1 EPS

Forte Biosciences (NASDAQ: FBRX) reported Q1 EPS of ($0.16), in-line with the analyst estimate of ($0.16).

For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• JPMorgan Starts Bechtle AG (BC8:GR) (BECTY) at Neutral
• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg